The Wall Street Transcript
The Wall Street Transcript - In-Depth Interviews for Investors
Healthcare >> CEO Interviews >> November 26, 2014

Interview with the President, CEO & Director: Capricor Therapeutics, Inc. (CAPR)

Marban, Linda
Linda Marban, Ph.D., is the President, CEO and Director of Capricor Therapeutics, Inc., a publicly traded biotechnology company, and Co-Founder of Capricor, Inc., a wholly owned subsidiary of Capricor Therapeutics. Dr. Marban has been with Capricor, Inc., since 2005 and became its Chief Executive Officer in 2010. She combines her background in research with her business experience to lead Capricor and create a path to commercialization for its novel stem-cell cardiac therapies. Dr. Marban was the lead negotiator in procuring the license agreements that are the foundation of Capricor, Inc.’s intellectual property portfolio. Under her direction as Chief Executive Officer, Capricor, Inc., secured approximately $27 million in nondilutive grants and a loan award, which funds Capricor, Inc.’s R&D programs and clinical trials involving its CAP-1002 product. From 2003 to 2009, Dr. Marban was with Excigen, Inc., a biotechnology startup company, where she was responsible for business development, operations, preclinical research and supervising the development of gene therapy products in a joint development agreement with Genzyme Corp. Dr. Marban began her career in academic science, first at the Cleveland Clinic Foundation working on the biophysical properties of cardiac muscle. That work continued when she moved to a postdoctoral fellowship at Johns Hopkins University. Dr. Marban earned a Ph.D. from Case Western Reserve University in cardiac physiology. Profile
TWST: I would like to begin with an overview of Capricor’s business.

Dr. Marban: Capricor, Inc., was founded in 2005 while Dr. Eduardo Marban and I were working at the Johns

Top Company Interviews

Microsoft Corporation
Intel Corporation
Pfizer, Inc.
General Electric Company
Walmart Inc.
International Business Machines Corporation
Citigroup Inc.
Exxon Mobil Corporation
Bank of America Corporation
Dell Inc.
Verizon Communications Inc.
Alphabet Inc

Register for a Free Account to gain greater access to The Wall Street Transcript right now

CEO INTERVIEWS
Interview with the President and CEO: PDS Biotechnology Corporation (NASDAQ:PDSB)
Interview with the Founder and Executive Chairman: Organovo Holdings Inc. (NASDAQ:ONVO)
Interview with the Co-Founder and CEO: Equillium Inc. (NASDAQ:EQ)
SECTOR ROUNDTABLES
Natural Gas Weighs Heavy On E&P Near-Term Prospects
Roundtable Forum:optimism Despite Uncertainty In For-profit Education
Roundtable Forum:a Shift In Focus To Natural Gas From Oil
MONEY MANAGER INTERVIEWS
Electric Cars and AI Fuel Long-Term Electricity Demand
Separating the Real Winners and Losers in the AI Boom
Generating Dividend Yield That’s Not Correlated to Interest Rates
ANALYST INTERVIEWS
Robust M&A Activity Provides Tailwind to Biotech Sector
Seeking Out Game Changers in Re-Emerging Biotech Sector
Obesity Drugmakers Still a ‘Buy’ Despite Lofty Valuations
Since 1963
© The Wall Street Transcript 2016, 2024
Terms and Conditions
Privacy Policy